Overall, cilomilast is well tolerated, with 4 clinical trials encompassing 1151 patients reporting the most common adverse effects to be diarrhea, nausea, dizziness, and headaches. [10,11,12,13 ...

Objective: To review available literature evaluating the pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of cilomilast, a selective phosphodiesterase-4 (PDE4) inhibitor ...